FDX1 and rheumatoid arthritis: Monocytes in RA prefer to use fatty acid oxidation to provide energy and drive receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclast survival and the associated bone destruction (65).FDX1 was found to significantly promote ATP production in these cells.